Efficacy of Topical Ketorolac Versus Placebo for Improving Visual Outcomes Following Multifocal IOL Implantation

NCT00433225 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Macula Thickening

Interventions

DRUG: Prednisolone Acetate
DRUG: Ketorolac 0.4%
DRUG: Gatifloxacin 0.3%

Sponsor

Innovative Medical